Artificial intelligence is entering one of the most sensitive areas of modern medicine: fertility treatment.

In vitro fertilization (IVF) already involves complex decisions, from ovarian stimulation and egg retrieval to embryo development and embryo transfer. AI is now being studied and, in some settings, introduced as a tool that can help fertility specialists analyze large amounts of medical and laboratory data.

But an important question remains:

Can artificial intelligence actually make IVF more successful?

The answer is more complicated than the headlines sometimes suggest.

How AI Is Being Used in IVF

AI systems can analyze information that would be difficult to process manually at the same speed.

In IVF laboratories, one of the most discussed applications is embryo assessment.

Embryos can be photographed or continuously monitored using time-lapse imaging. AI algorithms can analyze characteristics such as embryo morphology and developmental timing and use these patterns to estimate the likelihood of implantation or clinical pregnancy.

The American Society for Reproductive Medicine (ASRM) says AI could become a useful adjunct in the IVF laboratory, particularly for embryo selection, but emphasizes that clinical validation remains essential.

AI research is also examining areas such as sperm analysis, egg assessment, treatment planning and prediction of treatment outcomes.

A 2025 systematic review analyzed 48 studies examining AI in assisted reproductive technology and identified applications ranging from embryo and sperm analysis to personalized treatment planning and outcome prediction.

AI and Embryo Selection

Embryo selection is one of the most promising—and controversial—applications.

Traditionally, embryologists evaluate embryos based on characteristics such as appearance and developmental stage. AI systems can add another layer of analysis by examining images and developmental patterns.

The idea is not necessarily to replace an embryologist.

Instead, AI can act as a decision-support tool, helping specialists identify patterns that may not be immediately obvious.

However, promising algorithms do not automatically translate into better pregnancy outcomes.

What Does the Clinical Evidence Show?

One important randomized clinical trial published in Nature Medicine in 2024 compared deep-learning embryo selection with conventional morphology-based selection.

The study included 1,066 patients across 14 IVF clinics. Clinical pregnancy occurred in 46.5% of patients in the AI-assisted group compared with 48.2% in the conventional assessment group.

The researchers could not demonstrate that the AI approach was non-inferior to standard embryo selection for the primary outcome.

This is an important finding because it illustrates the difference between technological capability and proven clinical benefit.

An AI system may be very good at recognizing patterns without necessarily improving the final outcome for patients.

AI Could Help Make IVF More Personalized

Another potential advantage is personalization.

Every IVF cycle is different. Age, ovarian reserve, previous treatment history, laboratory results and many other factors can influence treatment decisions.

Machine-learning models are being studied to help predict outcomes and potentially support decisions about treatment timing and ovarian response.

Research has also examined whether machine-learning models can predict the number of eggs retrieved during assisted reproduction, although the available evidence remains heterogeneous and much of the research is retrospective.

The long-term goal is a more individualized approach:

The right treatment strategy for the right patient at the right time.

AI Does Not Replace Doctors or Embryologists

One of the biggest misconceptions about AI in fertility treatment is that an algorithm could independently decide which embryo should be transferred.

That is not the direction recommended by current professional guidance.

ASRM describes AI as a potential adjunct to IVF laboratory work and stresses the need for appropriate validation before widespread clinical adoption. The organization also highlights issues including the “black box” nature of some AI systems, data ownership and regulation.

Human expertise remains essential.

Doctors and embryologists understand the broader clinical context of an individual patient—something an algorithm may not fully capture.

The Challenge of AI "Black Boxes"

Some AI systems can produce highly accurate predictions without providing an easily understandable explanation of exactly how they reached a particular conclusion.

This creates an important question in reproductive medicine:

If an algorithm recommends one embryo over another, can clinicians and patients understand why?

Transparency becomes particularly important when decisions involve pregnancy and reproductive health.

Data quality is another challenge. AI models are only as reliable as the data used to train and validate them.

If datasets are limited to certain clinics, populations or laboratory systems, the results may not automatically apply everywhere.

What Could the Future Look Like?

AI could become an increasingly important tool throughout the IVF process.

Future systems may combine:

• Embryo images

• Time-lapse development data

• Patient medical history

• Hormone measurements

• Laboratory results

• Ovarian response data

• Other clinical variables

The goal would be to provide fertility specialists with a more comprehensive picture of each treatment cycle.

But the development of these technologies needs to be accompanied by high-quality clinical trials, transparent validation and appropriate regulation.

A 2025 review described AI in assisted reproductive technology as a developing field with considerable potential, while also noting that many studies still lack strong clinical validation.

Technology With Realistic Expectations

AI could make IVF laboratories more efficient and provide additional information for doctors and embryologists.

But it is important to separate potential from proven benefit.

Current evidence supports continued research into AI-assisted fertility care. It does not justify presenting AI as a guaranteed way to increase IVF success.

The most realistic future may therefore be a partnership:

Human expertise + laboratory technology + artificial intelligence.

AI can analyze enormous amounts of information. Doctors and embryologists provide clinical judgment, context and responsibility.

Together, these technologies could help shape the next generation of fertility treatment.

The Bottom Line

AI is no longer just a concept in fertility medicine. It is being actively studied and introduced into IVF laboratory workflows, particularly in embryo assessment and selection.

However, the technology is still developing.

For patients, the most important question is not simply whether a clinic uses AI.

It is whether the technology has been properly validated, how it is used, and whether it genuinely improves clinically meaningful outcomes.

The future of IVF may be increasingly intelligent—but it still needs evidence.

This article is for informational purposes and does not replace advice from a fertility specialist.